Cases and resources in vascular techniques
This section provides a selection of cases and resources provided by experts in vascular techniques.
In this SWEDEPAD sub-analysis, paclitaxel-coated devices were not associated with reduced one-year binary restenosis compared with uncoated devices. These findings, consistent with the main trial results, do not support routine use in an unselected infrainguinal PAD population.
Dr Eric Steinmetz discusses key themes from the French–German vascular surgery session, including asymptomatic carotid stenosis, CREST-2 data, surgical training, and AAA repair thresholds.
This case describes a ruptured abdominal aortic aneurysm complicated by an aortorenal fistula, presenting with massive hematuria and hemorrhagic shock in an emergency setting. It highlights an unusual clinical presentation of a life-threatening vascular pathology and the diagnostic challenges it may pose.
Dr Juliette Raffort-Lareyre interviews Dr Gilles Goyault on occlusive SFA ISR, discussing intraluminal strategies, debulking techniques, and the current lack of strong evidence.
At Charing Cross 2026, Dr Lichtenberg presented long-term data on venous stenting for acute and chronic femoral DVT. In a cohort of 80 patients followed for up to 8 years, most loss of patency occurred within the first 6 to 8 months, with early re-occlusion—likely linked to inflow issues—identified as the main cause of failure.
During a short interview recorded for PVI online at Charing Cross 2026, Prof. Secemsky discusses ongoing developments in bioresorbable scaffold technology and the key elements surrounding next-generation devices in below-the-knee intervention.
Through this publication review, discover the first-in-human evaluation of a teleoperated robotic system with haptic feedback for peripheral endovascular interventions.
In this PVI 2025 interview, Dr Hideaki Obara discusses why open surgery remains the preferred treatment for common femoral artery disease in Japan. He reviews data from a multicentre study showing low complication rates with common femoral endarterectomy and compares these findings with outcomes from endovascular approaches.
A 63-year-old man with multiple prior left carotid surgeries and a bovine aortic arch presented with a large carotid aneurysm. Open repair was high-risk, leaving the team to weigh complex anatomical and technical challenges. How should such a case be managed—and what was ultimately done?
In the SirPAD trial, sirolimus-coated balloon angioplasty significantly reduced major adverse limb events at 1 year compared with uncoated balloon angioplasty in patients undergoing endovascular treatment for infrainguinal artery disease, while maintaining a similar safety profile.
